MXPA04003750A - Canal cationico especifico de esperma, catsper2, y usos del mismo. - Google Patents

Canal cationico especifico de esperma, catsper2, y usos del mismo.

Info

Publication number
MXPA04003750A
MXPA04003750A MXPA04003750A MXPA04003750A MXPA04003750A MX PA04003750 A MXPA04003750 A MX PA04003750A MX PA04003750 A MXPA04003750 A MX PA04003750A MX PA04003750 A MXPA04003750 A MX PA04003750A MX PA04003750 A MXPA04003750 A MX PA04003750A
Authority
MX
Mexico
Prior art keywords
catsper2
methods
sperm
cation channel
protein
Prior art date
Application number
MXPA04003750A
Other languages
English (en)
Spanish (es)
Inventor
Ren Dejian
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of MXPA04003750A publication Critical patent/MXPA04003750A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MXPA04003750A 2001-10-22 2004-04-21 Canal cationico especifico de esperma, catsper2, y usos del mismo. MXPA04003750A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34532401P 2001-10-22 2001-10-22

Publications (1)

Publication Number Publication Date
MXPA04003750A true MXPA04003750A (es) 2004-07-23

Family

ID=23354573

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003750A MXPA04003750A (es) 2001-10-22 2004-04-21 Canal cationico especifico de esperma, catsper2, y usos del mismo.

Country Status (7)

Country Link
US (1) US7339029B2 (https=)
EP (1) EP1448589A4 (https=)
JP (1) JP2005512561A (https=)
AU (1) AU2002364939A1 (https=)
CA (1) CA2462670A1 (https=)
MX (1) MXPA04003750A (https=)
WO (1) WO2003054141A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729248B2 (en) 2001-10-22 2014-05-20 Children's Medical Center Corporation Sperm-specific cation channel, CATSPER2, and uses therefor
US20050202539A1 (en) * 2004-03-11 2005-09-15 Hydra Biosciences System for screening eukaryotic membrane proteins
WO2006049854A2 (en) * 2004-10-29 2006-05-11 Genentech, Inc. Disruptions of genes encoding secreted proteins, compositions and methods relating thereto
CA2612387A1 (en) 2005-06-15 2006-12-28 Hydra Biosciences, Inc. Modulators of sperm hypermotility and uses thereof
WO2014070786A1 (en) 2012-10-29 2014-05-08 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
JP7842564B2 (ja) 2018-09-21 2026-04-08 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 粘液を透過するのを制限するための合成結合剤
WO2020193446A1 (en) * 2019-03-22 2020-10-01 Westfälische Wilhelms-Universität Münster Catsper-activity-test for determining male infertility

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001054477A2 (en) 2000-01-25 2001-08-02 Hyseq, Inc. Novel nucleic acids and polypeptides
AU4072100A (en) * 1999-04-09 2000-11-14 Human Genome Sciences, Inc. 48 human secreted proteins
JP2003505082A (ja) 1999-07-26 2003-02-12 ジェネンテック・インコーポレーテッド 新規なポリヌクレオチドとその使用法
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
JP2004535794A (ja) * 2001-05-03 2004-12-02 チルドレンズ・メディカル・センター・コーポレイション 精子特異的カチオンチャネルおよびその使用
US20060026700A1 (en) * 2002-04-16 2006-02-02 Origene Technologies, Inc. Tissue specific genes and gene clusters
AU2003235096A1 (en) 2002-04-24 2003-11-10 Takeda Chemical Industries, Ltd. Novel protein and dna thereof
GB0212067D0 (en) * 2002-05-24 2002-07-03 Impharmatica Ltd Proteins
WO2004023973A2 (en) * 2002-09-12 2004-03-25 Incyte Corporation Molecules for diagnostics and therapeutics

Also Published As

Publication number Publication date
JP2005512561A (ja) 2005-05-12
EP1448589A4 (en) 2005-03-30
EP1448589A2 (en) 2004-08-25
US20050142566A1 (en) 2005-06-30
WO2003054141A3 (en) 2004-03-11
WO2003054141A2 (en) 2003-07-03
US7339029B2 (en) 2008-03-04
AU2002364939A1 (en) 2003-07-09
CA2462670A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
MXPA03010069A (es) Canal de cation especeifico de espermatozoide, y aplicaciones relacionadas con los usos para el mismo.
Marchal et al. Effect of follicular size on meiotic and developmental competence of porcine oocytes
Flesch et al. Dynamics of the mammalian sperm plasma membrane in the process of fertilization
CN105210981A (zh) 建立可应用于人类疾病研究的雪貂模型的方法及其应用
Honda et al. Stable embryonic stem cell lines in rabbits: potential small animal models for human research
Oura et al. Precise CAG repeat contraction in a Huntington’s Disease mouse model is enabled by gene editing with SpCas9-NG
Versieren et al. Developmental competence of parthenogenetic mouse and human embryos after chemical or electrical activation
Kadarmideen et al. Genomic selection of in vitro produced and somatic cell nuclear transfer embryos for rapid genetic improvement in cattle production
MXPA04003750A (es) Canal cationico especifico de esperma, catsper2, y usos del mismo.
AU4985201A (en) Human gene critical to fertility
US20090111764A1 (en) Mitochondrial selection
WO2004015066A3 (en) Sperm-specific cation channel, catsper-4, and uses therefor
WO2004015067A3 (en) Sperm-specific cation channel, catsper-3, and uses therefor
Muzaffar et al. Equivalency of buffalo (Bubalus bubalis) embryonic stem cells derived from fertilized, parthenogenetic, and hand-made cloned embryos
Pedersen et al. Basic and practical aspects of pregnancy establishment in cattle
Park et al. Production of plasminogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: effects of epidermal growth factor on production of PAs in oocytes and cumulus cells
AU2001274540A1 (en) Monkey-origin embryonic stem cells
Cruz et al. Putative imprinted gene expression in uniparental bovine embryo models
MXPA02010868A (es) Secuencias de nucleotidos involucrados en el incremento o disminucion en la ovulacion mamifera.
Escribá et al. Heteroparental blastocyst production from microsurgically corrected tripronucleated human embryos
EP4144857A1 (en) Animal preparation method
Savy et al. Effect of embryo aggregation on in vitro development of adipose-derived mesenchymal stem cell-derived bovine clones
Behr Blastocyst culture and transfer
Park et al. Comparison of normal and abnormal fertilization of in vitro‐matured human oocyte according to insemination method
WO2007095625A3 (en) VOLTAGE-GATED PROTON CHANNEL, Hv1, AND USES THEREFOR